The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay

Objectives: Reliable evidence suggests that anticipating the humoral response to coronavirus disease 2019 (COVID-19) vaccines is essential for predicting their clinical effectiveness. In this work, we sought to determine the extent to which the response of anti-SARS-CoV-2 antibodies BNT162b2 booster...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvagno, Gian Luca, Henry, Brandon M., Lippi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390096/
https://www.ncbi.nlm.nih.gov/pubmed/34455083
http://dx.doi.org/10.1016/j.ijid.2021.08.059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390096/
https://www.ncbi.nlm.nih.gov/pubmed/34455083
http://dx.doi.org/10.1016/j.ijid.2021.08.059

Ejemplares similares